Biomay AG

Vienna, AT
Plasmid
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
76.8
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (10) ○ MHRA GMP

Quick Facts: Biomay AG

Signal Score
76.8/100 (as of 2026-04-02)
Quality Compliance
100.0/100 — No FDA inspection records found for this manufacturer
Headquarters
Vienna, AT
Modalities
Plasmid
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance 100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates10 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesPlasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 53.0
1 manufacturing site: Vienna, AT
Modalities: Plasmid
Capacity assessment: 53.0/100
Sites: Vienna, AT
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Vienna, AT
Modalities: Plasmid
Capacity assessment: 53.0/100

EMA GMP Compliance 10 certificates

2025-10
2024-03
2024-03
2024-03
2024-03
2024-03
2023-11
2023-10
2022-03
2022-03
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
484219-103674986 Biomay AG Austria 2025-10-16 COMPLIANT
481719-104568656 Biomay AG Austria 2024-03-13 COMPLIANT
481719-103425951 Biomay AG Austria 2024-03-13 COMPLIANT
481719-102752478 Biomay AG Austria 2024-03-13 COMPLIANT
481719-104874230 Biomay AG Austria 2024-03-13 COMPLIANT
481719-102570085 Biomay AG Austria 2024-03-13 COMPLIANT
484219-101573243 Biomay AG Austria 2023-11-23 COMPLIANT
481719-101983357 Biomay AG Austria 2023-10-11 COMPLIANT
484219-100395448 Biomay AG Austria 2022-03-17 COMPLIANT
484219-102096252 Biomay AG Austria 2022-03-17 COMPLIANT
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Plasmid CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid
Aldevron
Fargo, ND
Signal Score: 84.8
Plasmid, mRNA
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 81.6
mRNA, Plasmid, Biologics